Josep Maria Haro and Ai Koyanagi among the most influential researchers worldwide
According to the ranking of the innovation company Clarivate Analytics, Dr. Ai Koyanagi and Dr. Josep Maria Haro are among the hundred most prominent experts who work in the Spanish State and lead projects with an international impact.
Gate2Brain receives funding from ”la Caixa” Foundation to accelerate its transfer to the market and society
Gate2Brain, a spin-off of Sant Joan de Déu (SJD), Institute for Research in Biomedicine (IRB) Barcelona and University of Barcelona (UB) will develop a new drug using a shuttle peptide that crosses the blood-brain barrier (BBB) to improve treatments for pediatric brain cancer.
Study reveals that a high percentage of children and adolescents with early onset psychosis suffer from clinical depression
A study carried out by researchers from the Institut Sant Joan de Déu and the Parc Sanitari Sant Joan de Déu reveals that a high percentage of children and adolescents with early onset psychosis suffer from clinical depression. The article has been published in the scientific journal European Child & Adolescent Psychiatry.
Loneliness multiplies by five the chances of developing depression
A study published in the Journal of affective disorders and led by Dr. Joan Domènech, researcher at the Institut de Recerca Sant Joan de Déu (IRSJD), determines that the probability that a person living in a situation of loneliness will develop depression is five times greater than one that does not have this kind of feeling.
Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections
A study, published in BMC Medicine, performed through the Kids Corona platform from Sant Joan de Déu in collaboration with ISGlobal, shows that measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections.
Two subtypes of retinoblastoma identified
Researchers from the Institut de Recerca Sant Joan de Déu have collaborated in a study, published in Nature Communications, which has identified two subtypes of molecular retinoblastoma with different genomic, clinical and pathological features.
Brown adipose tissue activity is higher in girls during the first year of life
A team led by Dr Lourdes Ibáñez and Dr Francesc Villarroya, IRSJD researchers, publishes the first study that shows the very early appearance of differences in the activity of the brown adipose tissue between girls and boys.
Researchers discover new phenotypic characteristics in inherited disorders of neurotransmitter metabolism
The study co-led by Dr Àngels Garcia-Cazorla, Institut de Recerca Sant Joan de Déu (IRSJD), has studied more than 270 patients with ultra-rare neuro-metabolic diseases to describe and evaluate their initial clinical and biochemical characteristics improve their diagnosis.
Detecting long QT syndrome early could help reduce the impact of sudden infant death
A team led by Dra. Georgia Sarquella (IRSJD) and Drs. Ramon Brugada and Oscar Campuzano (IDIBGI) provide new diagnostic measures to prevent sudden infant death from long QT syndrome.